• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Wedgewood Pharmacy Acquires Front Range Laboratories, Addressing a Growing Need for Testing Compounded Medications for Animal Health

Share:

March 7, 2023

Wedgewood Pharmacy has acquired Front Range Laboratories (FRL) in Loveland, CO, which is a full-service testing laboratory that has been a trusted partner of compounding pharmacies for more than 25 years. The transaction closed on February 23; terms were not disclosed. Excel Partners served as financial advisor to Wedgewood Pharmacy.

FRL provides analytical and microbiological testing as well as product stability and other services to support the testing needs of pharmacies across the country. FRL was founded by Michael Travis and Jennifer Travis, who will remain with the business and be part of the Wedgewood Pharmacy organization. Wedgewood Pharmacy plans to maintain the FRL brand, which is respected throughout the compounding pharmacy profession as a high-quality service provider.

Marcy A. Bliss, CEO of Wedgewood Pharmacy said: “Wedgewood Pharmacy and Wedgewood Connect, our 503B outsourcing facility, are significant clients of Front Range Laboratories. As we expand our reach in different sectors of compounding pharmacy, upcoming regulatory changes will increase demand across our companies for sterility and stability testing. By investing in a proven, high-quality in-house testing laboratory, we will be able to decrease testing turnaround time, better control our costs, and gain greater flexibility to respond rapidly to changes in demand. We will, of course, continue to do business with other specialized, high-quality testing laboratories. All of these will provide direct benefit to the more than 72,000 veterinarians in 29,000 practices we serve and their customers.”

Michael Travis added: “We’re in a strong position to contribute to Wedgewood Pharmacy’s rapid growth, as we have the immediate capacity to triple or quadruple the testing volume we can serve. We have proven to be a trusted partner to numerous compounding pharmacies, and we will continue to serve their needs as well. Wedgewood Pharmacy’s growth in animal health continues to outpace the industry. We expect that its investments will fuel our growth, in volume, capabilities, and staff.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Global Advanced Dermatology Drug Delivery Devices Market Worth $ 9.60 Billion By 2030 – Report By Insightace AnalyticsGlobal Advanced Dermatology Drug Delivery Devices Market Worth $ 9.60 Billion By 2030 – Report By Insightace Analytics
  • Cigna, Celgene join $23M funding round for AI-powered precision healthcare startupCigna, Celgene join $23M funding round for AI-powered precision healthcare startup
  • Probo Medical Acquires Elite Medical Technologies and Future Medical EquipmentProbo Medical Acquires Elite Medical Technologies and Future Medical Equipment
  • Third Rock raises $770M to build and grow more biotechsThird Rock raises $770M to build and grow more biotechs
  • Oscar Lands $140M More as It Prepares to Scale in 2021Oscar Lands $140M More as It Prepares to Scale in 2021
  • Femtech Market has Unmet Segments Despite Industry Growth, Report saysFemtech Market has Unmet Segments Despite Industry Growth, Report says
  • AI Researcher Daphne Koller Heading New Machine Learning Drug Discovery VentureAI Researcher Daphne Koller Heading New Machine Learning Drug Discovery Venture
  • Viome acquires Habit from Campbell Soup Company to become the undisputed leader in personalized healthViome acquires Habit from Campbell Soup Company to become the undisputed leader in personalized health

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications